Revium Rx (RVRC) Current Assets (2024 - 2025)

Revium Rx recorded quarterly Current Assets of $3.1 million in Q4 2025, down 43.9% quarter-over-quarter from $5.5 million in Q4 2024, and down 43.9% year-over-year from $5.5 million in Q4 2024.

Revium Rx's Current Assets history runs 2 years deep, the most recent figure standing at $3.1 million for Q4 2025.

  • In Q4 2025, Current Assets fell 43.9% year-over-year to $3.1 million; the TTM figure through Dec 2025 stood at $3.1 million (down 43.9% YoY), while the FY2025 annual figure was $3.1 million, down 43.9% from the prior year.
  • Current Assets came in at $3.1 million for Q4 2025 at Revium Rx, down from $5.5 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $5.5 million in Q4 2024 to a low of $3.1 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn 8.00 Bn
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn 2.69 Bn
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn 466.53 Mn
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn 540.05 Mn
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn 944.26 Mn
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn 386.61 Mn
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn 669.73 Mn
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn 966.02 Mn
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn 722.30 Mn
10 Revium Rx - - - 3.10 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 3.10 Mn
Dec 31, 2024 5.52 Mn